Evidence map›Paper›PMID 42818555›Full record

ArticlebioRxiv : the preprint server for biology2026

The diverse functions of viral microproteins.

Yi Hua Chen-Neumann, Louisa Grauvogel, Adam S Zhang, André C Michaelis, Tim Heymann, Elisabeth Zollbrecht, Paulina Engel, Christian Pensl, Kathryn E Yost, Wesley Suen and 7 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yi Hua Chen-NeumannComputational and Systems Biology, Massachusetts Institute of Technology; Cambridge, MA 02139, USA.ORCID 0000-0001-8864-8298
Louisa GrauvogelMax-Planck Institute of Biochemistry; Martinsried, Germany.ORCID 0009-0001-9460-0810
Adam S ZhangWhitehead Institute for Biomedical Research; Cambridge, MA 02142, USA.
André C MichaelisMax-Planck Institute of Biochemistry; Martinsried, Germany.ORCID 0000-0002-7519-3295
Tim HeymannMax-Planck Institute of Biochemistry; Martinsried, Germany.ORCID 0000-0002-6984-6894
Elisabeth ZollbrechtMax-Planck Institute of Biochemistry; Martinsried, Germany.
Paulina EngelGene Center, Department of Biochemistry, LMU Munich; Munich, Germany.
Christian PenslMax-Planck Institute of Biochemistry; Martinsried, Germany.
Kathryn E YostWhitehead Institute for Biomedical Research; Cambridge, MA 02142, USA.ORCID 0000-0001-6807-950X
Wesley SuenWhitehead Institute for Biomedical Research; Cambridge, MA 02142, USA.ORCID 0009-0001-4713-2110
Sumita SinhaWhitehead Institute for Biomedical Research; Cambridge, MA 02142, USA.ORCID 0000-0002-8681-2768
Edwin N NeumannWhitehead Institute for Biomedical Research; Cambridge, MA 02142, USA.ORCID 0000-0003-4341-9816
Stephen J ElledgeDivision of Genetics, Department of Medicine, Howard Hughes Medical Institute, Brigham and Women's Hospital; Boston, MA 02115, USA.ORCID 0000-0001-7923-6283
Karl-Peter HopfnerGene Center, Department of Biochemistry, LMU Munich; Munich, Germany.ORCID 0000-0002-4528-8357
Benjamin E GewurzDivision of Infectious Diseases, Mass General Brigham Hospital; Program in Virology, Harvard Medical School; Center for Integrated Solutions to Infectious Diseases, Broad Institute.ORCID 0000-0002-3965-3418
Matthias MannMax-Planck Institute of Biochemistry; Martinsried, Germany.ORCID 0000-0003-1292-4799
Jonathan S WeissmanWhitehead Institute for Biomedical Research; Cambridge, MA 02142, USA.ORCID 0000-0003-2445-670X

Funding

Targeting the Epigenetic and Metabolic Control of EBV-Epithelial CancersP01CA269043 · NCI · WISTAR INSTITUTE · PI Italo Tempera · 2023 to 2026
$12.0M
Project ILLUMINE - Exploiting the Dark Proteome to fight cancerOT2CA321158 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI JONATHAN S. WEISSMAN · 2026 to 2026
$782k
NCI NIH HHS OT2 CA321158NCI NIH HHS P01 CA269043
6 · The paper itself

Abstract

A large fraction of the uncharacterized proteome consists of microproteins. Viruses, rich in microproteins with potent activities, provide a unique system for exploring their functions and evolution. Here, we systematically annotate viral microproteins through a phenotype-first approach: construction of a >50,000-element small ORF library spanning the microprotein-coding potential of human-infecting viruses, followed by broad screens that enrich candidates for high-resolution profiling by Perturb-seq, mass spectrometry, AI-guided structure prediction, and mechanistic studies. This atlas identified >2,000 active microproteins that modulate host pathways through diverse mechanisms, including molecular mimicry, hijacking of key regulators, and altering subcellular localization. We further show the oncogenic potential of BNLF2b, an uncharacterized Epstein-Barr virus microprotein linked to nasopharyngeal carcinoma. Three principles emerge: viral microproteins are diverse and often multifunctional, show widespread convergence toward shared functions, and serve as reservoirs of evolutionary innovation. These findings elucidate how viral microproteins occupy a large functional landscape, establish them as versatile tools for host manipulation, and provide a framework for functional annotation of uncharacterized proteins, contributing toward predictive systems virology.

Identifiers

PMID42818555
PMCPMC13622983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.